首页> Leukemia & lymphoma> Busulfan is effective second-line therapy for older patients with Philadelphia-negative myeloproliferative neoplasms intolerant of or unresponsive to hydroxyurea.

Busulfan is effective second-line therapy for older patients with Philadelphia-negative myeloproliferative neoplasms intolerant of or unresponsive to hydroxyurea.

导出 LinkOut

翻译打印收藏纠错

第一作者： Genevieve,Douglas

第一单位： a Department of Clinical Haematology , Austin Hospital, University of Melbourne , Heidelberg , VIC , Australia.

作者： Genevieve,Douglas ^[1] ; Claire,Harrison ^[2] ; Cecily,Forsyth ^[3] ; Michael,Bennett ^[2] ; William,Stevenson ^[4] ; John,Hounsell ^[5] ; Sumita,Ratnasingam ^[6] ; David,Ritchie ^[6] ; David M,Ross ^[7] ; Andrew,Grigg ^[1]

作者单位： a Department of Clinical Haematology , Austin Hospital, University of Melbourne , Heidelberg , VIC , Australia. ^[1] b Department of Haematology , Guys and St Thomas' NHS Foundation Trust , London , UK. ^[2] c Wyong Hospital , Hamlyn Terrace , NSW , Australia. ^[3] d Royal North Shore , Sydney , NSW , Australia. ^[4] e Warrnambool Base Hospital , Warrnambool , VIC , Australia. ^[5] f Royal Melbourne Hospital , Parkville , VIC , Australia. ^[6] g Flinders University and Medical Centre and SA Pathology , Adelaide , SA , Australia. ^[7]

关键词 Philadelphia-negative myeloproliferative neoplasms busulfan hydroxyurea